• Fatores Associados À Compra De Medicamentos Em Brasília- Uma Análise Econométrica Com Dados Transversais De Base Populacional

    Nov 1, 2013, 00:00

  • Validity of Self-Reported Dose of Patients Using Wafarin in Clinical Practice

    Nov 1, 2013, 00:00

  • Level of Asthma Control and Health Care Utilization in Latin America

    Nov 1, 2013, 00:00

  • Differential Resource Use and Costs Among Inpatients and Outpatients with Schizophrenia in Tianjin, China

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Ceftaroline Versus Linezolid or Vancomycin on the Top of Standard Therapy in the Treatment of Complicated Skin and Soft Tissues Infections in Russian Federation

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Childhood Rotavirus Vaccination in Germany

    Nov 1, 2013, 00:00

  • The Humanistic and Economic Burden of Venous Thromboembolism in Cancer Patients- A Systematic Review

    Nov 1, 2013, 00:00

  • Adherence to Treatment and Persistency in Patients Treated with VKA in France, Italy, Germany, Spain and the United Kingdom

    Nov 1, 2013, 00:00

  • The Influence of Improved Adherence and Persistence in Chronic Obstructive Pulmonary Disease (COPD) Costs- Systematic Review of the Literature

    Nov 1, 2013, 00:00

  • The Burden of Disease Attributable to Physical Inactivity in the Austrian Region of Burgenland

    Nov 1, 2013, 00:00

  • Relative Efficacy and Acceptability of Vortioxetine Versus Marketed Antidepressants

    Nov 1, 2013, 00:00

  • Therapy Sequences in Multiple Myeloma – A Clinical Model Study in Regards of a German Cost Context

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in Mexico

    Nov 1, 2013, 00:00

  • Chronic Patients Response to the Implementation of International Non-Proprietary Name (INN) Prescribing in Greece

    Nov 1, 2013, 00:00

  • Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial

    Nov 1, 2013, 00:00

  • Análisis De Costos Mediante Un Modelo Lineal Generalizado De Pacientes Mexicanos Con Sindrome De West

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed Doublet Induction Treatment Followed by Pemetrexed Maintenance Compared with Bevacizumab Plus Cisplatin Plus Gemcitabine Triplet Induction Treatment Followed by Bevacizumab Maintena ...

    Nov 1, 2013, 00:00

  • Assessment of the Perception and Practices with Respect to Antibiotic Usage in Public Through Social Media

    Nov 1, 2013, 00:00

  • Dynamics of Quality of Life in Children with Cystic Fibrosis Aged 5-16 Years

    Nov 1, 2013, 00:00

  • A Budgetary Impact Analysis Model for Everolimus in the Treatment of ER+ HER2- Metastatic Breast Cancer in England and Wales

    Nov 1, 2013, 00:00

  • Attitudes, Beliefs and Behaviours of General Practitioners Regarding Vaccination- Development of a Characterisation Tool – Qualitative Steps

    Nov 1, 2013, 00:00

  • Análise Comparativa Dos Anticoncepcionais Orais Com Diferentes Concentraçoes De Etinilestradiol Em Relação Aos Perfis De Eficácia E De Adesão

    Nov 1, 2013, 00:00

  • Economic Evaluation of Tips Compared to Large Volume Paracentesis in Patients with Refractory Ascites

    Nov 1, 2013, 00:00

  • Treatment Costs of Ischemic Stroke Prevention and Management in Patients with Atrial Fibrillation (AF) in Latin America- Argentina, Brazil, Chile, and Venezuela

    Nov 1, 2013, 00:00

  • Assessing the Relationship Between the Diabetes Health Profile and Diabetes Specific Clinical Indicators- Case for Tailored Therapeutics

    Nov 1, 2013, 00:00

  • A Systematic Review of Antidepressants in Irritable Bowel Syndrome- A Qualitative Analysis

    Nov 1, 2013, 00:00

  • Following the Western HTA Model in Latin America- A Self-Fulfilling Prophecy?

    Nov 1, 2013, 00:00

  • The Impact of Indication Extensions on Pharmaceutical Prices

    Nov 1, 2013, 00:00

  • Utilization of the Hungarian Publicly Financed Health Care System by Third (Non EU) Country Citizens

    Nov 1, 2013, 00:00

  • Cost-Utility of Active Surveillance for the Treatment of Localized Prostate Cancer in the Context of the German Health Care System

    Nov 1, 2013, 00:00

  • Systematic Literature Review in Moderate to Severe Ulcerative Colitis

    Nov 1, 2013, 00:00

  • Relationship Between Body Mass Index and Health Care Costs by Place of Service in Employed Adults

    Nov 1, 2013, 00:00

  • Health Outcomes of Female Anabolic-Androgenic Steroid Users

    Nov 1, 2013, 00:00

  • Three-Year Health Care Expenditures in Diabetic Patients Receiving Rapid-Acting Insulin Analogues Versus Those on Human Regular Insulin

    Nov 1, 2013, 00:00

  • A Retrospective Study Comparing Compliance, Persistence, and Blood Pressure Control Between Free-Drug and Single-Pill Combination Therapies in Korean Hypertensive Patients

    Nov 1, 2013, 00:00

  • Pivotal Studies of Orphan Medicinal Products – an Analysis of Quality of Clinical Evidence

    Nov 1, 2013, 00:00

  • Using a Cause-Of-Death-Based Mortality Model to Identify the Individuals Who Would Benefit Most from Primary Prevention with Statins

    Nov 1, 2013, 00:00

  • Impact of Patient Weight Trajectory on Cost-Effectiveness of Treatments of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2013, 00:00

  • The Economic Footprint of the Greek Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • A Critical Appraisal of Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening- Making Appropriate Comparisons and Usefully Interpreting Results

    Nov 1, 2013, 00:00

  • Cost of Illness of Neuropathic Pain in Spain in 2012 from a Societal Perspective

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Atorvastatin Compared to Simvastatin in the Prevention of Cardiovascular Diseases in the Czech Republic

    Nov 1, 2013, 00:00

  • Squaring the Circle- Innovative Contracting to Achieve Market Access for Innovative Products

    Nov 1, 2013, 00:00

  • Chronic Patients’ Access to Physicians Services in Times of Economic Crisis

    Nov 1, 2013, 00:00

  • Prescribing Patterns of Parkinson’s Disease

    Nov 1, 2013, 00:00

  • Clinical Effectiveness Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Caspofungin Versus Voriconazole for Empiric Therapy in Turkey

    Nov 1, 2013, 00:00

  • The Costs of Surgical Aortic Valve Replacement in France

    Nov 1, 2013, 00:00

  • Venous Thromboembolism in Gynae-Oncology Patients Post Surgery – Is Tinzaparin Prophylaxis an Effective Anticoagulant?

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analysis of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis- A Scottish Perspective

    Nov 1, 2013, 00:00

  • Measuring Treatment Effects on Rare Events Using Meta-Analysis- An Assessment of Existing Methods

    Nov 1, 2013, 00:00

  • Explaining the Increased Health Care Expenditures Among Individuals with Co-Occurring Chronic Obstructive Pulmonary Disease and Gastroesophageal Reflux Disease- A Cost-Decomposition Analysis

    Nov 1, 2013, 00:00

  • Indirect and Direct Savings Resulted from Parallel Trade of Pharmaceuticals in Poland – Results of Valuation Sales Data from Public Pharmacies

    Nov 1, 2013, 00:00

  • Appropriate Evidence Sources for Populating Decision Analytic Models Within Health Technology Assessment (HTA)- A Systematic Review of HTA Manuals and Health Economic Guidelines

    Nov 1, 2013, 00:00

  • Evaluation of the Policies Implemented to Monitor Prescription and Reduce Pharmaceutical Expenditure at the University General Hospital of Patras, Greece

    Nov 1, 2013, 00:00

  • Pertussis in Brazilian Children- Mortality, Length of Stay, and Costs in Hospitalized Patients

    Nov 1, 2013, 00:00

  • Screening Strategies for Heart Failure in Patients with Type 2 Diabetes- Assessing Cost-Effectiveness in Those Aged 60 Years or Over

    Nov 1, 2013, 00:00

  • Meta-Analysis of Quality of Life in Coronary Heart Disease

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Benefits of Citicoline in the Treatment of Acute Ischemic Stroke in Russia

    Nov 1, 2013, 00:00

  • A Time-Motion Comparison of Itemized Treatment Costs in First Versus Subsequent Cycles of in Vitro Fertilization (IVF)- Treatments Can Optimized for Improving Outcomes While Increasing Patient Volumes in Cost-Constrained Regions

    Nov 1, 2013, 00:00

  • The Relative Economic Value of Ipilumumab in Colombia

    Nov 1, 2013, 00:00

  • Quality Criteria for the Development of Implant Registries

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis in Institutional Market in Ecuador

    Nov 1, 2013, 00:00

  • Incidence/Prevalence, Risk Factors and Complications of Type 2 Diabetes Mellitus in Indian Patients- A Systematic Review and Meta-Analysis

    Nov 1, 2013, 00:00

  • Epidemiological and Economic Impact of Chronic Kidney Disease in Patients with Hypertension and Diabetes in Colombia

    Nov 1, 2013, 00:00

  • The Impact of Smoking on Hospital Costs in Times of Crisis; An Additional Burden to the Vulnerable Greek Health Care System

    Nov 1, 2013, 00:00

  • Quality Improvement Initiatives for Patients on Warfarin in Primary Care

    Nov 1, 2013, 00:00

  • Treatment Patterns Among Type 2 Diabetes Mellitus Patients in Dubai

    Nov 1, 2013, 00:00

  • A Cost-Utility Analysis of Everolimus Plus Exemestane for the Treatment of ER+ HER2- Metastatic Breast Cancer in the United Kingdom

    Nov 1, 2013, 00:00

  • The Hybrid Purchaser-Provider Split in England- Should Europe Follow Suit?

    Nov 1, 2013, 00:00

  • Network Meta-Analysis with Fractional Polynomials for Repeated Trough FEV1 Measures in COPD- Aclidinium Bromide 400 μG Bid Versus Tiotropium 18 μG QD

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Early Versus Delayed Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy in Adults Aged 40+ in France

    Nov 1, 2013, 00:00

  • The Use of European Electronic Health Records to Investigate Cancer Treatment Pathways

    Nov 1, 2013, 00:00

  • Cost Analysis of Pulmonary Arterial Hypertension in a Tertiary Care Setting in Mexico City

    Nov 1, 2013, 00:00

  • ePRO Migration and Usability Testing of Patient-Reported Outcome (PRO) Measures

    Nov 1, 2013, 00:00

  • Generating and Maintaining Momentum in Post-Authorisation Studies

    Nov 1, 2013, 00:00

  • Individually Tailored Elastic Compression Therapy for the Prevention of Post Thrombotic Syndrome

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad De Intervenciones Para El Manejo Del Trastorno Depresivo Mayor (TDM) En Pacientes Con Virus De La Inmunodeficiencia Humana (VIH+) Que Inician Tratamiento Antirretroviral De Gran Actividad (TARGA)

    Nov 1, 2013, 00:00

  • How Does Prescription of Generic Drugs Spread Out?- Data Mining and Visualization by Using Prescription Data Form Acute Care Hospitals Nationwide

    Nov 1, 2013, 00:00

  • Desigualdad En Salud Relativa Al Ingreso En Chile- Análisis De Descomposición Del Índice De Concentración En Hipertensión, Diabetes Y Depresión

    Nov 1, 2013, 00:00

  • Agranulocytosis Detection Outcome By Clozapine Treatment (Adoc Study) in Psychiatry- A Cost-Effectiveness Study

    Nov 1, 2013, 00:00

  • Resource Utilization and Costs for Patients with Inflammatory Bowel Diseases in Italy- A Population-Based Assessment

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of School-Based Health Promotion in Canada- A Life-Course Modeling Approach

    Nov 1, 2013, 00:00

  • Paediatric Tuberculosis - Costs to the Irish Health Care Payer

    Nov 1, 2013, 00:00

  • Do Policy Measures Impact on Cost Consciousness of Health Care Professionals?

    Nov 1, 2013, 00:00

  • Cost of Treatment After Renal Transplantation in Iran- Should Government Continue Paying for New Expensive Immunosuppressive Drugs?

    Nov 1, 2013, 00:00

  • Impacto Financiero Del Tratamiento Farmacológico En Pacientes Adultos Con Enfermedad De Gaucher Tipo 1 En México

    Nov 1, 2013, 00:00

  • Hepatocellular Carcinoma- An Epidemiological and Management Survey-Based Analysis in Italy

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness and Cost-Utility Analysis of Belimumab for the Treatment of Patients with Systemic Lupus Erythematosus in Portugal

    Nov 1, 2013, 00:00

  • Design of Lupus Impact Tracker (LIT) Validation Study in Five European Clinical Practice Settings

    Nov 1, 2013, 00:00

  • Accessibility of Orphan Drugs in France, United Kingdom and Germany- Different Approaches with Regard to HTA and Prices

    Nov 1, 2013, 00:00

  • Can We Use the EQ-5D Only for Assessing the Quality of Life of Patients with Osteoporosis?

    Nov 1, 2013, 00:00

  • Direct-To-Patient Contact and Proactive Pharmacovigilance System- A Case Study

    Nov 1, 2013, 00:00

  • Treating Psoriatic Arthritis with Biological Disease Modifying Antirheumatic Drugs- Systematic Review and Meta-Analysis to Evaluate Efficacy and Safety

    Nov 1, 2013, 00:00

  • Comparison Between Everolimus (Afinitor®) and Chemotherapy Agents (Capecitabine, Docetaxel and Doxorubicin) for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast Cancer

    Nov 1, 2013, 00:00

  • Health Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease in North India

    Nov 1, 2013, 00:00

  • Carbon Cost-Effectiveness of Cocooning Immunization Against Pertussis in England and Wales- An Ecological Perspective

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analyses of Natalizumab for 2nd Line Versus Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients in Brazil

    Nov 1, 2013, 00:00

  • Clinical and Health Economic Evidence Requirements for Obtaining Health Insurance Coverage for Innovative Medical Devices in Germany

    Nov 1, 2013, 00:00

  • Number of Submissions Needed to Reach a Positive Reimbursement Decision from SMC, CADTH, and PBAC

    Nov 1, 2013, 00:00

  • Costo Del Automonitoreo Glucémico En Pacientes En Tratamiento Combinado Oral Y Con Insulina En Argentina

    Nov 1, 2013, 00:00

  • Differences in Medical Cost and Survival Between Trial and Non-Trial Patients with Acute Myeloid Leukaemia – A UK Population-Based Propensity Analysis

    Nov 1, 2013, 00:00

  • The Health and Economic Impact of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) in Columbia- A Transmission Dynamic Model-Based Evaluation

    Nov 1, 2013, 00:00

  • Disease Burden Among Patients with Psoriatic Arthritis Who Have Experienced First Line Tumor Necrosis Factor Inhibitor Regimen Failure in the European Union

    Nov 1, 2013, 00:00

  • The Use of Data from Published Kaplan-Meier Survival Curves in NICE HTAs

    Nov 1, 2013, 00:00

  • Confirmatory Factor Analysis and Evaluation of Clinically Important Differences in Menopause-Specific Quality of Life Associated with Bazedoxifene/Conjugated Estrogens in a Vulvar/Vaginal Atrophy Population

    Nov 1, 2013, 00:00

  • Construcción De Un Modelo De Priorización Aplicable a Latinoamérica – El Caso De Colombia

    Nov 1, 2013, 00:00

  • Methodology of an Observational Study to Evaluate the Care Map of Women with Postmenopausal Osteoporosis (PMO) in Switzerland

    Nov 1, 2013, 00:00

  • Long-Term Fiscal Implications of Funding Assisted Reproductive Therapies- A Generational Accounting Model for Spain

    Nov 1, 2013, 00:00

  • Iceberg Phenomenon of Heart Failure in Hospitalized Patients- A Multicentric Cross Sectional Study

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Intravenous Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme in Russia

    Nov 1, 2013, 00:00

  • Item Refinement and Psychometric Testing of a Novel Survey for Evaluating Patient Perception and Preference for Haemophilia a Treatment

    Nov 1, 2013, 00:00

  • Assessment of Generic Drug Policy Implementation by Measuring Persistence with Antihypertensive Drug Therapies After Patent Expiry

    Nov 1, 2013, 00:00

  • Cost Minimization Analysis of the Dienogest Use in Patients with Endometris under Brazilian Public and Private Perspective

    Nov 1, 2013, 00:00

  • Retrospective Analysis of Oncology Indications Utilizing Drug Expenditures from 2005 to 2012 in the Republic of Srpska

    Nov 1, 2013, 00:00

  • Custo-Efetividade Do Tratamento Para Osteoporose Na Pos-Menopausa No Brasil

    Nov 1, 2013, 00:00

  • 4-Valent Vaccine Patients – Statistical Assessment of a New Estimation Methodology

    Nov 1, 2013, 00:00

  • Systematic Review on the Impacts of Strict Pharmaceutical Price Controls

    Nov 1, 2013, 00:00

  • Japanese Representation in Leading General Medicine and Basic Science Journals- A Comparison of Two Decades

    Nov 1, 2013, 00:00

  • Costs and Effectiveness of Non-Smoking Clinic

    Nov 1, 2013, 00:00

  • The Effectiveness of Statins in the Treatment of Cardiovascular Disease- Cross-Sectional Study with Paired Groups from Electronic Patient Records

    Nov 1, 2013, 00:00

  • Patient Reported Outcomes with Multiple Sclerosis in Slovakia

    Nov 1, 2013, 00:00

  • The Cost of Producing a Unit of Blood in Hospitals- A Nationwide Economic Analysis for the Case of Greece

    Nov 1, 2013, 00:00

  • Likelihood of Use and Perception Towards Biosimilars in Rheumatoid Arthritis Arena- Survey of Rheumatologists in European Union, Brazil, Japan and China

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Alendronate Therapy for Secondary Prevention of Osteoporotic Fractures

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Metastatic Colorectal Cancer (mCRC)- A Utilities Study in the United Kingdom and the Netherlands

    Nov 1, 2013, 00:00

  • Trends in Chemotherapy Setting and Costs from 2005 to 2012- A Case Study Using Bevacizumab

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany

    Nov 1, 2013, 00:00

  • A Systematic Review of Patient Reported Outcomes in Glaucoma

    Nov 1, 2013, 00:00

  • Effectiveness and Cost Analysis of the Smoking Cessation Program in the Public Health System in Brazil

    Nov 1, 2013, 00:00

  • Factorial Invariance of the Whoqol-Old Across Gender, Age, and Resident Area in Taiwan

    Nov 1, 2013, 00:00

  • Health State (QALY) Values for Multiple Sclerosis- A Report Using Data from the United Kingdom South West Impact of Multiple Sclerosis (SWIMS) Study

    Nov 1, 2013, 00:00

  • Disease Burden in Epilepsy Associated with Tuberous Sclerosis Complex- Systematic Review

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Cinacalcet Chronic Kidney Disease Patients on Dialysis with Secondary Hyperparathyroidism in Brazilian Public Health Care System (SUS)

    Nov 1, 2013, 00:00

  • Uptake of Denosumab in the Treatment of Osteoporosis in the Czech Republic

    Nov 1, 2013, 00:00

  • A Price Comparison Study of Recent Drugs in EU5, 2008-2012

    Nov 1, 2013, 00:00

  • Use of Multivariate Bayesian Evidence Synthesis to Reduce Uncertainty Around Clinical Effectiveness and Quality of Life Estimates

    Nov 1, 2013, 00:00

  • Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erithematosus in the Italian Setting- A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • The Impact of DSM-5 on the Development of Drugs to Treat Schizophrenia

    Nov 1, 2013, 00:00

  • A Cost Analysis of Medication for Patients with Type 2 Diabetes Mellitus (T2DM) – How This Varies According to Body Mass Index (BMI) Status, Age, Gender and Co-Morbidity

    Nov 1, 2013, 00:00

  • Short Run Dynamics of Inadequate Pain Relief (IPR)- Evidence from a European Multinational Survey of Real World Therapies (SORT)

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Assessment of Different Tactics of COPD Treatment in Russia

    Nov 1, 2013, 00:00

  • Economic Impact of a Smoking Cessation Program in Mexico- Enrolling Employees and Employers

    Nov 1, 2013, 00:00

  • Clinical and Economic Analysis of Mometasone Furoate Nasal Spray in the Treatment of Rhinosinusitis in Mexico

    Nov 1, 2013, 00:00

  • Costs and Outcomes Associated with Multidrug Resistant Staphylococcus Aureus Bacteremia

    Nov 1, 2013, 00:00

  • Exploring Dependence on Others in Alzheimer’s Disease

    Nov 1, 2013, 00:00

  • An Assessment of the Use of Utility Data in Long-Term Cost-Effectiveness Models of Lipid Lowering Therapies

    Nov 1, 2013, 00:00

  • Clinical Outcomes Assessments in Schizophrenia- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Burden of Dose Escalation with Biologics in Rheumatoid Arthritis- A Review of Frequency and Costs

    Nov 1, 2013, 00:00

  • A Systematic Review of Economic Evidence in Hepatitis C- An Overview of Cost, Utility and Cost-Effectiveness Data

    Nov 1, 2013, 00:00

  • A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC)

    Nov 1, 2013, 00:00

  • Recruting Physicians for Health Outcome and Post-Approval Studies- Benefits of a Managed Physician Panel

    Nov 1, 2013, 00:00

  • Cost-Comparison Between Different Treatment Regimens in Diabetes Mellitus in Germany Based on Long Acting Insulins

    Nov 1, 2013, 00:00

  • Modelling Uncertain Future Events in Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany

    Nov 1, 2013, 00:00

  • Analysis of the Pricing and Market Access Landscape of Orphan Drugs in Latin America

    Nov 1, 2013, 00:00

  • The Relationship Between Treatment Satisfaction and Adherence in COPD Patients in 5 Countries

    Nov 1, 2013, 00:00

  • How to Select the Right Cost-Effectiveness Model? A Systematic Review and Stepwise Approach for Transferring an Existing Health Economic Model for Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Incorporating Stakeholder Input into Budget Impact Models to Compare Stem Cell Mobilization Strategies

    Nov 1, 2013, 00:00

  • Counting the Cost of Meningococcal Disease in France

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Children and Young People with Chronic Hepatitis C from the Perspective of the NHS in England and Wales

    Nov 1, 2013, 00:00

  • Direct Health Care Costs of Patients Switching Biologic Therapies in Chronic Plaque Psoriasis

    Nov 1, 2013, 00:00

  • Revised Scoring of the WPAI-Hep C Improves Assessment of Missed Work and Work Impairment in HCV Clinical Trials

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Posaconazole Versus Fluconazole for Prevention of Invasive Fungal Infections in Patients with Graft-Versus-Host Disease in Sweden

    Nov 1, 2013, 00:00

  • Compliance Protects Against Fracture in Women with Postmenopausal Osteoporosis in Hungary

    Nov 1, 2013, 00:00

  • Resource Consumption Evaluation Associated with Rituximab Administration in Portugal

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan

    Nov 1, 2013, 00:00

  • Standardized Tool for Measurement of Health Services Costs and Utilization in a Sample with Mental Disorders- Translation, Cultural Adaptation and Interrater Reliability of the Client Sociodemografic and Service Receipt Inventory Brazilian ...

    Nov 1, 2013, 00:00

  • Inpatient Hospital Costs of Febrile Neutropenia (FN) as a Consequence of Chemotherapy (CHT) for Breast Cancer (BC) and Non-Hodgkin Lymphoma (NHL) in Switzerland

    Nov 1, 2013, 00:00

  • Relevance of a National Forecast Growth Rate, as a Regulation Tool of the Expensive Hospital Drug Spending, in France

    Nov 1, 2013, 00:00

  • Current Situation of Oral Anticancer Treatments Use in Fran The Actor Study (Analysis of Cancer Treatments Given Orally)

    Nov 1, 2013, 00:00

  • The Disease Burden of Influenza in Germany

    Nov 1, 2013, 00:00

  • Relationship Between Modelling Approach and Reported Outcomes- Case Studies of Models for the Treatment of Schizophrenia

    Nov 1, 2013, 00:00

  • Economic Analysis of Use of Harmonic Devices in Inpatient Laparoscopic Cholecystectomy in the United States

    Nov 1, 2013, 00:00

  • Quantifying Health Care Efficiency- A Review of Published Time and Motion Study Design Parameters Referenced in Pubmed Between 2008-2013

    Nov 1, 2013, 00:00

  • Evaluating Different Modes of Radiotherapy Based on a Patient-Level Simulation Model

    Nov 1, 2013, 00:00

  • Economic Impact of Improving the Accuracy of Blood Glucose Self-Monitoring on the Spanish Health Service

    Nov 1, 2013, 00:00

  • Conceptual and Practical Considerations when Dealing with Missing Utility Data in Longitudinal Trials, and Subsequent Use in Cost-Effectiveness Analyses

    Nov 1, 2013, 00:00

  • Household Feeding Practices for the Sick Under Five Children; Gucha South District-Kisii County, Kenya

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Type 2 Diabetes in Poland- Comparison with General Population Using EQ-5D Questionnaire

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of First-Line Treatment of Advanced Metastatic Non Small Cell Lung Cancer- A Systematic Review of Economic Models

    Nov 1, 2013, 00:00

  • Effectiveness of Different Dosage Regimen of Pralidoxime in Organophosphorus Poisoning in Tertiary Care Hospital

    Nov 1, 2013, 00:00

  • Relationship Between Medication Adherence and Quality of Life in COPD – Systematic Review

    Nov 1, 2013, 00:00

  • Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also known as C. Difficile-Associated Diarrhoea (CDAD) in Ireland

    Nov 1, 2013, 00:00

  • Effect of Ivabradine on Thai Chronic Stable Angina Pectoris Patients

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Aspects of Actovegin and Solcoseryl in the Treatment of Russian Patients with Acute Cerebrovascular Accidents

    Nov 1, 2013, 00:00

  • Comparing the Value of Different HTA Decision Making Process- Evaluating the Evaluators

    Nov 1, 2013, 00:00

  • Mapping from PDQ-39 and PDQ-8 Onto EQ-5D Utility Index in Patients with Parkinson’s Disease- Extended Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Boceprevir Add-On Treatment of Hepatitis C Virus Genotype 1 Patients in Denmark

    Nov 1, 2013, 00:00

  • A Cost-Analysis of Stereotactic Radiotherapy in Lung Cancer

    Nov 1, 2013, 00:00

  • Health State in Patients with Atrial Fibrillation on New Oral Anticoagulants as Assessed with the New EQ-5D-5L Questionnaire- Prefer in AF Registry

    Nov 1, 2013, 00:00

  • Public Health Impact and Cost Effectiveness of Pneumococcal Vaccination for Adults in Puerto Rico

    Nov 1, 2013, 00:00

  • Level and Factors Impacting the Patient Dissatisfaction in the Primary Care Visits Based on the Cross-Section Measurement – a Prospective Finnish Study

    Nov 1, 2013, 00:00

  • Impacto En La Productividad Laboral De Una Cohorte De Pacientes Con Artritis Reumatoide Tratados Con Etanercept (Enbrel®) En Colombia

    Nov 1, 2013, 00:00

  • Do Nice Evidence Review Groups (ERG) Focus on Different Aspects of Manufacturer Submissions in Oncology?

    Nov 1, 2013, 00:00

  • Application of Copulas in Economic Evaluation

    Nov 1, 2013, 00:00

  • Canadian Private Payers’ Perceptions and Expectations of Submission Requests for Drug Reimbursement Submitted by the Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Development of the Schizophrenia Caregiver Questionnaire- Modification of the Zarit Burden Interview Informed by Qualitative Insights

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Health Care Resource Utilization

    Nov 1, 2013, 00:00

  • Beta-Thalassemia Patients Survey on Deferrization Therapy

    Nov 1, 2013, 00:00

  • Impact of Autism Spectrum Disorders on the Family – A National Perspective

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Enzyme Replacement Therapy (ERT) with Alglucosidase Alfa in Classic-Infantile Patients with Pompe Disease

    Nov 1, 2013, 00:00

  • Varicella Vaccine as Post-Exposure Prophylaxis – a Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Systematic Testing for Lynch Syndrome in Patients Newly Diagnosed with Colorectal Cancer in the United Kingdom

    Nov 1, 2013, 00:00

  • Demineralised Bone Matrix (DBM) Versus Iliac Crest Bone Graft (ICBG) for Lumbar Spinal Fusion Procedures in the United Kingdom; A Budget-Impact Analysis

    Nov 1, 2013, 00:00

  • Side-Effects of Antiepileptic Drugs- The Economic Burden

    Nov 1, 2013, 00:00

  • A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Linezolid Versus Vancomycin in the Treatment of Ventilator Associated Pneumonia in Jamaica

    Nov 1, 2013, 00:00

  • G-Ba Assessments of Oncology Trials- Is Increased Overall Survival a “Must Have”?

    Nov 1, 2013, 00:00

  • Is Hospitalized Multi-Morbidity in Adults Determining Costs of Re-Admission? Evidence from a Multicentric Cross Sectional Study in Argentina

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Botulinum Toxin a Therapy for Upper Limb Spasticity in the United Kingdom

    Nov 1, 2013, 00:00

  • Telemonitoring After Discharge from Hospital with Heart Failure – Cost-Effectiveness Modelling of Alternative Service Designs

    Nov 1, 2013, 00:00

  • How Complex Is the Competition in Regulated Pharmaceutical Markets?

    Nov 1, 2013, 00:00

  • Evolution of Oral Anticancer Treatments Use in France from 2004 – 2012- Re-Actor Study (Retrospective Analysis of Cancer Treatments Given Orally)

    Nov 1, 2013, 00:00

  • Comparison of Treatment Satisfaction in Patients with Asthma Taking Leukotriene Modifiers Verus Those Taking Inhaled Corticosteroids

    Nov 1, 2013, 00:00

  • Obtaining Optimal Personalized Surveillance Strategies for Patients with Screen-Detected Colorectal Adenomas Using Discrete Event Simulation

    Nov 1, 2013, 00:00

  • What Factors Predict the Decision to Treat Acute Coronary Syndrome Invasively? Evidence from Clinical Practice

    Nov 1, 2013, 00:00

  • Lower Short-Term Health Care Cost with the Accu-Chek Aviva Expert System in Multiple Daily Insulin Injection (MDI) Treated Diabetes Patients - Learnings from the Automated Bolus Advisor Control and Usability Study (ABACUS)

    Nov 1, 2013, 00:00

  • Reliability and Validity of the Pediatric Quality of Life Inventory Generic Core Scales for Dutch Children with Functional Constipation

    Nov 1, 2013, 00:00

  • Literature Review and Assessment to Populate a Decision-Analytic Model Evaluating a Novel Prognostic in Early Lung Cancer

    Nov 1, 2013, 00:00

  • Evaluation of the Burden of Illness of Colorectal Cancer Among Veteran Patients in the United States

    Nov 1, 2013, 00:00

  • Systematic Review on the Cost-Effectiveness of Therapeutic Education to Prevent the Development and Progression of Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Real World Incidence of Type 2 Diabetes (T2D) Complications Leading to Hospitalization in Fran The Recode Study

    Nov 1, 2013, 00:00

  • Spectacle Independence and Vision-Related Quality of Life in Cataract Surgery Patients Following Implantation of a Multifocal Intraocular Lens

    Nov 1, 2013, 00:00

  • Patient-Level Costs of Cardiovascular Events and Procedures- How Robust Is the Evidence?

    Nov 1, 2013, 00:00

  • Influence of One Week Education Program on the Knowledge and Approach of Pharmacy Students Towards Diabetes Mellitus

    Nov 1, 2013, 00:00

  • A Mixed Treatment Comparison (MTC) to Compare Progression Free Survival (PFS) Associated with Different Chemotherapy Regimens for Platinum-Sensitive or Partially Platinum-Sensitive Recurrent Advanced Ovarian Cancer

    Nov 1, 2013, 00:00

  • EMA Approval of Drugs on the Basis of Pivotal Non-Comparative Phase II Trial Data

    Nov 1, 2013, 00:00

  • Sustained Improvements in Productivity at Paid Work and Within Household, and Increased Participation in Daily Activities Over Time with Certolizumab Pegol in Patients with Psoriatic Arthritis- 48-Week Results from the Rapid-PsA Study

    Nov 1, 2013, 00:00

  • Cost Assessment of Metastatic and Non-Metastatic Castration-Resistant Prostate Cancer Patient-Management in Spain

    Nov 1, 2013, 00:00

  • Description of Treatment Pathways in Chronic Diseases Using Large General Practitioner Longitudinal Data- The Example of Pharmaco-Therapy in Parkinson’s Disease in the United Kingdom

    Nov 1, 2013, 00:00

  • Table of Contents

    Nov 1, 2013, 00:00

  • Cost-Consequence Analysis of a Treatment Strategy Including Ponatinib Compared to a Treatment Strategy Including Only the 2nd Generation Tyrosine Kinase Inhibitors (2g TKIs), Dasatinib or Nilotinib, in Resistant Patients with Philadelphia C ...

    Nov 1, 2013, 00:00

  • Methodological Challenges of Cost-Of-Illness Studies on Dementia- An International Systematic Review

    Nov 1, 2013, 00:00

  • Treatments for EGFR Mutation Positive NSCLC – A Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

    Nov 1, 2013, 00:00

  • Economic Impact of Pruritus Among End-Stage Renal Disease Patients Receiving Hemodialysis

    Nov 1, 2013, 00:00

  • The Analysis of Costs and Reimbursements for Lung Cancer Treatment in the Czech Republic

    Nov 1, 2013, 00:00

  • Guidance for Partnership Working Between CatSalut and the Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Economic Burden of Venous Thromboemoblism Across Patient Populations- A Literature Review

    Nov 1, 2013, 00:00

  • A Novel Algorithm Using Claims Data to Identify Patients with Castration-Resistant Prostate Cancer (CRPC)

    Nov 1, 2013, 00:00

  • The Cost-Utility of Insulin Degludec Compared with Current Standard of Care in the Management of Type One and Type Two Diabetes Mellitus in Belgium

    Nov 1, 2013, 00:00

  • Measuring Patient-relevant Treatment Benefit in Dermatology – Development and Validation of the Short Questionnaire “Patient Benefit Index 2.0”

    Nov 1, 2013, 00:00

  • Evaluation of the Cost-Effectiveness of the Capsaicin Patch Qutenzatm for the Treatment of Peripheral Neuropathic Pain in the United Kingdom

    Nov 1, 2013, 00:00

  • Acute Exposure of Bisphenol-A from Electronic Gadgets Does Not Induce Oxidative Stress in the Rat Brain

    Nov 1, 2013, 00:00

  • Management of Obese Women During Pregnancy Across Europe According to Clinical Practice Guidelines

    Nov 1, 2013, 00:00

  • Comparison of Markov and Discrete Event Simulation Modeling Techniques with Application to Cost Effectiveness Analyses

    Nov 1, 2013, 00:00

  • The Importance of Patient Reported Outcomes in Reimbursement of Orphan Products in Europe

    Nov 1, 2013, 00:00

  • Utility Values Used in National Institute for Health and Care Excellence (NICE) Technology Appraisals of Medicines for 4 Metastatic Cancers

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation of the Oral Hypoglycemic Agents in the Treatment of Type 2 Diabetes Mellitus Patients in the Russian Federation

    Nov 1, 2013, 00:00

  • The French Public Health Care System- An Original Way for Cost Saving

    Nov 1, 2013, 00:00

  • Cost Associated with Adverse Events and Health Care Resources Utilization in Hepatitis C Virus Infection in Quebec, Canada

    Nov 1, 2013, 00:00

  • Patient Satisfaction with HIV Therapies- Focus on Adherence to Treatment

    Nov 1, 2013, 00:00

  • Economic Evidence of Surgical Procedures in Cancer- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Multi-Criteria Benefit-Risk Assessment of Biological Agents in the Treatment of Moderate to Severe Psoriais- A Stochastical Approach

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy

    Nov 1, 2013, 00:00

  • The Cost of Treating Squamous Cell Carcinoma of the Anus (SCCA) in England- Results from an Empirically Calibrated Model

    Nov 1, 2013, 00:00

  • Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly- A Discrete Choice Study

    Nov 1, 2013, 00:00

  • Cost and Length of Stay Associated with Vancomycin-Induced Nephrotoxicity

    Nov 1, 2013, 00:00

  • Application of a Data Visualization Tool- Treatment Patterns of Veteran Patients with Ankylosing Spondylitis

    Nov 1, 2013, 00:00

  • Clinical Outcomes in Schizophrenia Treated with Donepezil in Combination with Antipsychotics

    Nov 1, 2013, 00:00

  • Comparing Virtual Colonography with Conventional Colonoscopy for Colorectal Cancer Screening- What are the Drivers of Cost-effectiveness?

    Nov 1, 2013, 00:00

  • Cost Analysis of Anti-Migraine Prescribing Using a Claims Database

    Nov 1, 2013, 00:00

  • Comparative Costs Analysis of Conventional Strategy Versus Step-Down Strategy with Linezolid in the Treatment of Nosocomial Pneumonia Caused by Gram Positive Bacteria in Mexico

    Nov 1, 2013, 00:00

  • Multi-Dimensional Capture of Patient-Relevant Endpoints in Regulatory Trials and Health Technology Assessments in Oncology Two Years After Introduction of the German Amnog Health Care Reform

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Linaclotide in the Treatment of Irritable Bowel Syndrome with Constipation in Belgium

    Nov 1, 2013, 00:00

  • Trends in Reimbursement Decisions in Ireland- An Analysis of the NCPE Database from an Industry Perspective

    Nov 1, 2013, 00:00

  • Patterns of Use of Tests to Diagnose and Assess Disease Progression in Multiple Sclerosis (MS)- A Multicountry Comparison

    Nov 1, 2013, 00:00

  • Coverage with Evidence Development in Sweden – Formality or Effective Way to Reduce Uncertainty?

    Nov 1, 2013, 00:00

  • Atopic Dermatitis in Adults- Design and Validation of a Specific Burden Questionnaire

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Treatment of Spasticity with Botulinum Toxin Type A

    Nov 1, 2013, 00:00

  • Quadrivalent Versus Trivalent Influenza Vaccine- Is It Good Value for Money?

    Nov 1, 2013, 00:00

  • The Cost Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Hepatitis C in Children and Young People

    Nov 1, 2013, 00:00

  • Network Meta-Analysis of Approved Biologic Interventions for the Maintenance of Response in Ulcerative Colitis

    Nov 1, 2013, 00:00

  • Impact of Short Periods with Improved or Worsened INR Control on Life Expectancy and QALYs in Patients with Atrial Fibrillation

    Nov 1, 2013, 00:00

  • Economic Analysis of the Prevention of Medical Sharps Injuries with Safety-Engineered Devices- A Systematic Review

    Nov 1, 2013, 00:00

  • The Influence of Choice Task Layout on the Outcomes of a Discrete Choice Experiment

    Nov 1, 2013, 00:00

  • The Burden of Treatment Change in Major Depressive Disorder- Comparison of Switch Versus Non-Switch Patients in the Perform Study

    Nov 1, 2013, 00:00

  • Study of Quality of Life and Costs for CML Patients in Bulgaria

    Nov 1, 2013, 00:00

  • Assessing the Impact of Organized Screening for Abdominal Aorta Aneurysms in Austria – Following Eunethta Core Information

    Nov 1, 2013, 00:00

  • A Review of Cost-Effectiveness Evaluations as Part of National HTA Assessments of Biologic Dmards in the Treatment of Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Screening for Silent Atrial Fibrillation After Ischaemic Stroke

    Nov 1, 2013, 00:00

  • The Annual Treatment and Rehabillitation Costs of Patients with Paraplegia in the Private Health Care Setting in Greece

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated with Docetaxel from the Perspective of the Brazilian Private Health Care System

    Nov 1, 2013, 00:00

  • A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Medication Errors-Incidence, Causes and Possible Prevention Strategies in Indian Health Care Setting

    Nov 1, 2013, 00:00

  • Adherence by Spanish Retinologists to the Guidance for the Management of Patients with Wet Age-Related Macular Degeneration

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Asenapine Versus Atypical Antipsychotics Used in Turkey in the Treatment of Bipolar I Disorder

    Nov 1, 2013, 00:00

  • Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

    Nov 1, 2013, 00:00

  • Assessing the Significance of HbA1c Durability in Cost Effectiveness Analysis of 2nd Line Oral Therapies in the Management of Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Impact of Reimbursement of Medicines on Economic Accessibility Level for Working Population in Republic of Moldova

    Nov 1, 2013, 00:00

  • Cost-Effectiveness and Cost-Utility Analysis of Mifamurtide Plus Combination Chemotherapy in Pediatric Patients with Osteosarcoma After Resection Surgery

    Nov 1, 2013, 00:00

  • Prototype Model in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)- A Tool to Position New Treatments in the Patient Pathway?

    Nov 1, 2013, 00:00

  • Linezolid for the Treatment of Patients with Confirmed MRSA Nosocomial Pneumonia in Nanjing, China- A Cost Effective Alternative to Vancomycin

    Nov 1, 2013, 00:00

  • The Role of DSM in the EMA and FDA Authorization Process for Psychiatric Drugs

    Nov 1, 2013, 00:00

  • Decision Making in HIRA for 5 Years of Positive List System

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Combined Treatment of Metformin and Fenofibrate on Retinopathy Progression

    Nov 1, 2013, 00:00

  • Patient Preferences in the Choice of Disease Modifying Drugs for Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Evaluation of the Burden of Illness of Skin Cancer Among Veteran Patients United States

    Nov 1, 2013, 00:00

  • Characterizing Disease Burden in an Ultra-Rare Disease in the United States- Transthyretin (TTR) Amyloidosis Patients Caregivers

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of 3 Candins and Fluconazole in the Treatment of Confirmed Invasive Candidiasis in Adult Non-Neutropaenic Patients in Spain

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in Costa Rica

    Nov 1, 2013, 00:00

  • Antibacterial Treatment of Meticillin-Resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections- A Cost-Effectiveness Analysis in Greece

    Nov 1, 2013, 00:00

  • EU Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement Decisions

    Nov 1, 2013, 00:00

  • Costo E Impacto Presupuestal Del Tratamiento Del Cáncer De Púlmon De Celulas No Pequeñas Del Tipo Adenocarcinoma Con Grado Ecog 0,1,2 En Estadio Iv Con Mutación + (EGFR O ALK) Con Terapias Blanco En México

    Nov 1, 2013, 00:00

  • Analysis of Mandibular Test Specimens Used to Evaluate Bone Fixation Systems

    Nov 1, 2013, 00:00

  • Patient Survey- Investigation on What Impacts Patient Satisfaction, Drop-Out and Compliance in Patient Diaries

    Nov 1, 2013, 00:00

  • Evaluating Overall Survival in Oncology Trials with Subsequent Therapies- A Methodological Review and Application in Non-Small Cell Lung Cancer

    Nov 1, 2013, 00:00

  • First Russian Type 2 Diabetes Mellitus Simulation Model with Discrete Events Modeling. Health-Economic Analysis

    Nov 1, 2013, 00:00

  • Abiraterone Acetate Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer Post Chemotherapy- Cost Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Is Drug Innovation Still Rewarded in the Top 5 European Pharmaceutial Markets?

    Nov 1, 2013, 00:00

  • Assessing the Burden of Caregiving for Patients with Lung Cancer in Europe

    Nov 1, 2013, 00:00

  • Qualidade De Vida Dos Pacientes Que Utilizam Medicamentos Anti-TNF Para O Tratamento De Doenças Reumáticas No Sistema Único De Saúde Em Minas Gerais, Brasil

    Nov 1, 2013, 00:00

  • Non-Homogeneous Cost-Effectiveness Modeling of a New CHG-Dressing for Preventing Catheter-Related Bloodstream Infections for Patients in Intensive Care Units

    Nov 1, 2013, 00:00

  • Characteristics of Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Inhaled Corticosteroid/Long-Acting b2-ß2-agonist (ICS/LABA) Fixed Combination Products in English Primary Care

    Nov 1, 2013, 00:00

  • Pathological Gambling- A Growing Addiction

    Nov 1, 2013, 00:00

  • Covering the PASS- Development of Protocol Template Language (PTL) for Data Collection and Data Management (DM) in Post-Authorization Safety Studies (PASS)

    Nov 1, 2013, 00:00

  • Efectividad Y Costo-Efectividad De La Fluoración Del Agua En La Prevención De Caries Dental

    Nov 1, 2013, 00:00

  • Costo E Impacto Presupuestal Del Tratamiento De La Artritis Reumatoide Moderada Y Severa Considerando El Uso De Terapias Biológicas En México

    Nov 1, 2013, 00:00

  • Study of Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Symptom Assessment Differences Between Patients and Family Members

    Nov 1, 2013, 00:00

  • Costs of Formal and Informal Home Care and Quality of Life of Patients with Multiple Sclerosis in Sweden

    Nov 1, 2013, 00:00

  • The Effect of Medical Devices with Dose-Memory and Reminder Functions on Patients’ Treatment Adherence, Confidence and Disease Self-management

    Nov 1, 2013, 00:00

  • A UK Case Study of Societal and Herd-Effect Impact of Universal Mass Influenza Vaccination in the United Kingdom

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Direct Medical Costs Among Patients with Schizophrenia in Tianjin, China

    Nov 1, 2013, 00:00

  • The Budget Impact of Introducing Bg-12 (Dimethyl Fumarate) for Treatment of Relapse-Remitting Multiple Sclerosis (RRMS) in Canada

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Progestogen Preparations for Threatened Abortion Treatment in Ukraine

    Nov 1, 2013, 00:00

  • Reduction in NSAIDS Consumption After Viscosupplementation with HA- Is It Costs Saving?

    Nov 1, 2013, 00:00

  • A Systematic Review of Economic Evidence in Hepatitis C- Methods Used in Recent Economic Evaluations

    Nov 1, 2013, 00:00

  • Burden of Varicella in Latin America- A Systematic Review and Critical Analysis

    Nov 1, 2013, 00:00

  • Impact of Public Payer Concentration on Public Sector Discounts for Selected Cancer Supportive Care Products in Brazil and Mexico

    Nov 1, 2013, 00:00

  • Classification of Cognitive Dysfunction and Cognitive Normal Using Scores from Four Cognitive Assessments in Patients with Depressive Disorder

    Nov 1, 2013, 00:00

  • StratafixTM Knotless Tissue Control Devi A Budget Impact Analysis from Italian Health Service Perspective

    Nov 1, 2013, 00:00

  • Cross (-Walk) at Your Own Peril! Comparing and Contrasting Cea Results When Individual-Level Utilities Are Derived from External Mapping Algorithms Rather Than Actually Observed Responses

    Nov 1, 2013, 00:00

  • Grade for Quality Assessment of Efficacy and Effectiveness Studies on Anti-TNFs Treatment of Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • The Attendance of the Fourth Screening Round (2008-2009) of the Hungarian Organized, Nationwide Breast Cancer Screening Program

    Nov 1, 2013, 00:00

  • Health Economics Assessment of the Cnamts Sophia Diabetic Patient Support Programme- Results of the First 4 Years

    Nov 1, 2013, 00:00

  • Delay of Total Hip Replacement (THR) Using HA Viscosupplementation- Is Cost Effective?

    Nov 1, 2013, 00:00

  • Methodology for Establishing Internal and External Validity When Propensity Score Matching Is Used

    Nov 1, 2013, 00:00

  • Prevalence of Risk Factors of St Elevated Myocardial Infarction

    Nov 1, 2013, 00:00

  • Analyses Adjusting for Selective Crossover Show Improved Overall Survival with Decitabine Compared with Treatment Choice in DACO-016 Phase III Trial

    Nov 1, 2013, 00:00

  • How Much Does Benign Prostatic Hyperplasia Cost? A Budget Impact Analysis on Italian Patients Treated with 5α-Reductase Inhibitors

    Nov 1, 2013, 00:00

  • Ruling Out IBD in the United Kingdom and Brazil- Is the Usage of F-Calprotectin in Primary Care Cost-Effective?

    Nov 1, 2013, 00:00

  • A Systematic Comparison of Market Access and Reimbursement Pathways for Diagnostic Tests in Germany, United Kingdom and the United States

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Cost of Illness Study

    Nov 1, 2013, 00:00

  • Exploring Gender Differences in Population-Based Prevalences of Cardiovascular Diseases in Chile After the Health Care Reform of 2005

    Nov 1, 2013, 00:00

  • Patient-Reported Outcome (PRO) Claims in Products Approved for Chronic Obstructive Pulmonary Diseases (COPD) in Europe and the United States

    Nov 1, 2013, 00:00

  • Comparison of Elderly Adults by Number of Rx Medications Used- Results from the National Health and Wellness Survey Across 5EU Countries

    Nov 1, 2013, 00:00

  • Costs of Management of Pregnancy in Obese Women Across Europe- The Dali Experience

    Nov 1, 2013, 00:00

  • Acceptance of Surrogate Endpoints by HTA Agencies in Europe

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life in Patients Along First Year Poststroke in Spain

    Nov 1, 2013, 00:00

  • A Low Antiviral Treatment Rate in Chronic Heptitis C Patients in Taiwan- A Nationwide Physician-Based Survey

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation of the Fixed-Dose Combination of Abacavir/Lamivudine in the Antiretroviral Therapy of Naïve HIV Infected Patients in Russia

    Nov 1, 2013, 00:00

  • The Value of Pilot Testing Pro Symptom Diaries Prior to Conducting Cognitive Debriefing Interviews in Children/Adolescents- Qualitative and Quantitative Insights

    Nov 1, 2013, 00:00

  • Comparison of Disease Status, Treatments and Outcomes of Patients with Psoriatic Arthritis Receiving Their First Biologic in the European Union and United States

    Nov 1, 2013, 00:00

  • Anticoagulation Treatment with VKA in France, Italy, Germany, Spain and United Kingdom. Results from the React AF Study

    Nov 1, 2013, 00:00

  • Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with the Hepatitis C Virus in the United States

    Nov 1, 2013, 00:00

  • Determinantes De Los Costos De Accidentes De Tránsito Ocurridos En Medellín (Colombia) 2009-2010

    Nov 1, 2013, 00:00

  • Riociguat for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)- Responder Analysis of Who Functional Class III Patients from the Patent-1 Study

    Nov 1, 2013, 00:00

  • Abiraterone and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post Chemotherapy- An Indirect Comparison and Budget Impact Analysis

    Nov 1, 2013, 00:00

  • Direct and Indirect Burden Associated with Parents Whose Infant Has Been Hospitalized for a Lower Respiratory Tract Infection (LRTI) in Greece

    Nov 1, 2013, 00:00

  • Estimating Chronic Disease PREVALENCE from Claims Data- Reducing Bias by Accounting for Diseased Individuals Who Do Not Generate Claims

    Nov 1, 2013, 00:00

  • Economic Evaluation of Direct Acting Antiviral (DAA) Treatments for Hepatitis C Virus (HCV) Infection in Previously Treated Patients from the Peruvian Health Care System Perspective

    Nov 1, 2013, 00:00

  • Modeling Medication Adherence in Comparative Effectiveness Research

    Nov 1, 2013, 00:00

  • Differences in Approach to Biosimilars- Nice Versus SMC Recommendations

    Nov 1, 2013, 00:00

  • Exploring the Key Decision Drivers Provided by HTA Agencies Rejecting Submissions with ICERs Lower Than the Threshold

    Nov 1, 2013, 00:00

  • Payer Assessment and Reimbursement Policy for Rare Diseases- A Review of the Literature

    Nov 1, 2013, 00:00

  • Cancer Patients May Have a Different Point of View on Oncology Drug Coverage Decisions Than Non-Patients

    Nov 1, 2013, 00:00

  • Causal Analysis of Longitudinal Patient Turnover Data at Hepatitis-C

    Nov 1, 2013, 00:00

  • Confidential Patient Access Schemes in the United Kingdom – Do They Affect Prices in Other Markets?

    Nov 1, 2013, 00:00

  • Dynamic Modeling of Vector-Borne Diseases (VBD)- The Example of Malaria

    Nov 1, 2013, 00:00

  • The Impact of Sacral Neuromodulation on EQ-5D Index Scores and Costs to Manage Overactive Bladder

    Nov 1, 2013, 00:00

  • Web-Based of Topic Selection for Comparative Effectiveness Research in Korea

    Nov 1, 2013, 00:00

  • Overcoming the HTA Hurdle in Germany- Key Considerations for a Manufacturer’s Pricing and Market Access Strategy

    Nov 1, 2013, 00:00

  • The Health of Health Technology Assessment in Ireland- Five Points for Improvement

    Nov 1, 2013, 00:00

  • Medication Adherence and Adverse Health Outcomes in Community Dwelling Older Patients

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Argentina

    Nov 1, 2013, 00:00

  • The Impact of DSM-5 on the Development of Drugs to Treat Attention-Deficit/Hyperactivity Disorder

    Nov 1, 2013, 00:00

  • Screening Characteristics and Diabetes Biomarkers in French and UK Patient-Level Databases

    Nov 1, 2013, 00:00

  • A Choice of Business for the Pharmaceutical Industry “Seguro Popular” in Mexico

    Nov 1, 2013, 00:00

  • Biosimilar and Originator Biologic Pricing Dynamics in Emerging Markets

    Nov 1, 2013, 00:00

  • The Cost of Stopping (Futility) Rules Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients in Brazil

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Dl Tratamiento Profiláctico Versus a Demanda En Adultos Jóvenes Con Hemofilia a Severa En Colombia

    Nov 1, 2013, 00:00

  • Croatia’s EU Accession in the Context of International Reference Pricing- What Will Be the Wider Impact for Pricing and Reimbursement?

    Nov 1, 2013, 00:00

  • Analysis of Total Treatment Costs of Organophosphorous Poisoning in a Tertiary Care Hospital

    Nov 1, 2013, 00:00

  • Use of Antenatal Corticosteroids Lowers Hospitalization Costs Related to Prematurity

    Nov 1, 2013, 00:00

  • Análisis De Minimización De Costos De Iobitridol Versus Otros Medios De Contraste Iodados Iso E Hipo-Osmolales En Población General

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in Japan

    Nov 1, 2013, 00:00

  • The Determinants of Innovation – A Brief Study of Issues Influencing Innovation in the Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Indirect Comparison of Joint Damage Prevention with Adalimumab V. Abatacept, Each in Combination with Methotrexate, in Early Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Pharmaceutical Regulation in Europe and Its Impact on Corporate RD

    Nov 1, 2013, 00:00

  • Exploring the Feasibility of the Instrument Used in Determination of Willingness-To-Pay Per Quality-Adjusted Life-Year in Malaysia

    Nov 1, 2013, 00:00

  • Results of a Study Using a Tablet PC to Collect PROs in Elderly Population

    Nov 1, 2013, 00:00

  • Patient-Level Markov Model to Assess Economic Impact of New Antipsychotics Introduction in Schizophrenia

    Nov 1, 2013, 00:00

  • Agreement Between Child and Parent Symptom Diary Responses in Chronic Constipation (CC) and Irritable Bowel Syndrome with Constipation (IBS-C)- Implications for the Measurement of Symptoms in Young Children

    Nov 1, 2013, 00:00

  • Lifetime Cost-Effectiveness of Isolated and Concomitant Aortic Valve Replacements in Germany

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Universal Paediatric Rotavirus Vaccination with RIX4414 in Greece

    Nov 1, 2013, 00:00

  • Orphan Drug Access- Risk/Reward Analysis of Local Clinical Development in Chile

    Nov 1, 2013, 00:00

  • Hepatitis C Virus Infection Treatment Completion- An Analysis of the Quebec Provincial Reimbursement Program Database

    Nov 1, 2013, 00:00

  • How Does Hospitalization Impact Insulin Treatment in Diabetes Mellitus? Results of a Retrospective German Database Analysis

    Nov 1, 2013, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115 (current)
  • 116
  • 117
  • 118
  • 119
  • 120
  • »